Single dose pharmacokinetic equivalence study of two gabapentin preparations in healthy subjects

References

• Sweetman SC Martindale: The Complete Drug Reference 36th ed New York, NY The Pharmaceutical Press 2009 482 484
   Google Scholar
• Berry DJ Beran RG Plunkeft MJ Clarke LA Hung WT The absorption of gabapentin following high dose escalation Seizure 2003 12 1 28 36 12495646
   PubMed Web of Science ®Google Scholar
• Browne TR Efficacy and safety of gabapentin Chadwick D New Trends in Epilepsy Management: The Role of Gabapentin London Royal Society of Medicine Services Ltd 1993 41 46
   Google Scholar
• Chadwick D The role of gabapentin in epilepsy management Chadwick D New Trends in Epilepsy Management: The Role of Gabapentin London Royal Society of Medicine Services Ltd 1993 59 65
   Google Scholar
• Rose MA Kam PC Gabapentin: pharmacology and its use in pain management Anaesthesia 2002 57 5 451 462 11966555
   PubMed Web of Science ®Google Scholar
• Backonja M Glanzman RL Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials Clin Ther 2003 25 1 81 104 12637113
   PubMed Web of Science ®Google Scholar
• Singh D Kennedy DH The use of gabapentin for the treatment of postherpetic neuralgia Clin Ther 2003 25 3 852 889 12852705
   PubMed Web of Science ®Google Scholar
• Backonja M Beydoun A Edwards KR Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial JAMA 1998 280 21 1831 1836 9846777
   PubMed Web of Science ®Google Scholar
• Morello CM Leckband SG Stoner CP Moorhouse DF Sahagian GA Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain Arch Intern Med 1999 159 16 1931 1937 10493324
   PubMed Web of Science ®Google Scholar
• Banerjee M Pal S Bhattacharya B Ghosh B Mondal S Basu J A comparative study of efficacy and safety of gabapentin versus amitriptyline as coanalgesics in patients receiving opioid analgesics for neuropathic pain in malignancy Indian J Pharmacol 2013 45 4 334 338 24014906
   PubMed Web of Science ®Google Scholar
• McLean MJ Clinical pharmacokinetics of gabapentin Neurology 1994 44 6 Suppl 5 S17 S22 ; discussion S31–S32. 8022536
   PubMed Web of Science ®Google Scholar
• Gidal BE Maly MM Kowalski JW Rutecki PA Pitterle ME Cook DE Gabapentin absorption: effect of mixing with foods of varying macronutrient composition Ann Pharmacother 1998 32 4 405 409 9562133
   PubMed Web of Science ®Google Scholar
• Committee for Medicinal Products for Human Use (CHMP) European Medicines Agency (EMA) Guideline on the Investigation of Bioequivalence. Rev 1 London European Medicines Agency 2010 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf Accessed August 28, 2014
   Google Scholar
• Badan Pengawas Obat dan Makanan Republik Indonesia (BPOM RI) Pedoman Uji Bioekuivalensi. [Indonesian Guideline for Bioequivalence Studies] Jakarta BPOM 2004 Available from http://jdih.pom.go.id/showpdf.php?u=89 Accessed August 28, 2014 Indonesian
   Google Scholar
• Badan Pengawas Obat dan Makanan Republik Indonesia (BPOM RI) Peraturan Kepala BPOM RI Nomor. HK.03.1.23.12.11.10217. Tahun 2011 Tentang Obat Wajib Uji Bioequivalensi [BPOM-RI Regulation for Drugs Compulsory for Bioequivalence Studies] Jakarta BPOM 2011 Available from http://jdih.pom.go.id/showpdf.php?u=97 Accessed August 28, 2014 Indonesian
   Google Scholar
• fda.gov [homepage on the Internet] Orange book preface Approved drug products with therapeutic equivalence evaluations 34th ed Food and Drug Administration 2014 [updated March 14, 2014; cited June 12, 2014]. Available from: http://www.fda.gov/drugs/developmentapprovalprocess/ucm079068.htm Accessed August 4, 2014
   Google Scholar
• 52nd World Medical Association General Assembly Declaration of Helsinki Recommendations Guiding Physicians in Biomedical Research Involving Human Patients Edinburgh World Medical Association 2000
   Google Scholar
• International Conference on Harmonisation (ICH) Expert Working Group ICH Harmonised Tripartite Guideline Guideline for Good Clinical Practice E6(R1) Geneva International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use 1996
   Google Scholar
• Organization for Economic Co-operation and Development (OECD) OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring. Number 1. OECD Principles on Good Laboratory Practice Revised Paris Organization for Economic Co-operation and Development (OECD) 1997
   Google Scholar
• Yamada M Welty TE Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies Ann Pharmacother 2011 45 11 1406 1415 22028417
   PubMed Web of Science ®Google Scholar
• Wittayalertpanya S Chompootaweep S Thaworn N Khemsri W Intanil N Bioequivalence study of two different formulations of 300 mg gabapentin capsule in Thai healthy volunteers Thai J Pharm Sci 2008 32 70 76
   Google Scholar
• Cho HY Kang HA Lee YB Pharmacokinetics and bioequivalence evaluation of two gabapentin preparations after a single oral dose in healthy Korean volunteers Int J Clin Pharmacol Ther 2006 44 8 386 392 16961169
   PubMed Web of Science ®Google Scholar
• Almeida S Filipe A Almeida A Comparative study on the bioequivalence of two different gabapentin formulations. A randomised, two-period, two-sequence, crossover clinical trial in healthy volunteers Arzneimittelforschung 2006 56 2 59 63 16572918
   PubMed Web of Science ®Google Scholar
• Yu Y Teerenstra S Vanmolkot F Neef C Burger D Maliepaard M Interchangeability of gabapentin generic formulations in the Netherlands: a comparative bioavailability study Clin Pharmacol Ther 2013 94 4 519 524 23708746
   PubMed Web of Science ®Google Scholar
• Zhu Z Neirinck L High-performance liquid chromatographic method for the determination of gabapentin in human plasma J Chromatogr B Analyt Technol Biomed Life Sci 2002 779 2 307 312
   Web of Science ®Google Scholar
• Gidal BE Radulovic LL Kruger S Rutecki P Pitterle M Bockbrader HN Inter- and intra-subject variability in gabapentin absorption and absolute bioavailability Epilepsy Res 2000 40 2–3 123 127 10863139
   PubMed Web of Science ®Google Scholar
• Sagirli O Cetin SM Onal A Determination of gabapentin in human plasma and urine by high-performance liquid chromatography with UV-vis detection J Pharm Biomed Anal 2006 42 5 618 624 16822634
   PubMed Web of Science ®Google Scholar
• Park JH Jhee OH Park SH Validated LC-MS/MS method for quantification of gabapentin in human plasma: application to pharmacokinetic and bioequivalence studies in Korean volunteers Biomed Chromatogr 2007 21 8 829 835 17428017
   PubMed Web of Science ®Google Scholar
• Diletti E Hauschke D Steinijans VW Sample size determination for bioequivalence assessment by means of confidence intervals Int J Clin Pharmacol Ther Toxicol 1991 29 1 1 8 2004861
   PubMed Web of Science ®Google Scholar